Fluorescence in situ hybridization of TP53 for the detection of chromosome 17 abnormalities in myelodysplastic syndromes.

Sánchez-Castro, Judit

Fluorescence in situ hybridization of TP53 for the detection of chromosome 17 abnormalities in myelodysplastic syndromes. [electronic resource] - Leukemia & lymphoma 2015 - 3183-8 p. digital

Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

1029-2403

10.3109/10428194.2015.1028053 doi


Chromosome Banding
Chromosome Deletion
Chromosomes, Human, Pair 17
Humans
In Situ Hybridization, Fluorescence
Myelodysplastic Syndromes--genetics
Tumor Suppressor Protein p53--genetics